Sign in

CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850642577
Phone
650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,410
in 2 filings

Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lettmann Jason −$4K CHIEF EXECUTIVE OFFICER sold <1% of stake
  2. Wong Shelly −$1K SVP, FINANCE AND CAO sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2020-07-21 Hemrajani Rekha Director Purchase +3,000 $19.00 $57K 3,000
2020-07-21 GOODMAN COREY S Director Conversion +3,100,020 3,969,789
2020-07-21 GOODMAN COREY S Director Purchase +850,000 $19.00 $16.1M 850,000
2020-07-21 GOODMAN COREY S Director Conversion +3,941,949 5,268,325
2020-07-21 GOODMAN COREY S Director Conversion +93,969 113,287
2020-07-21 GOODMAN COREY S Director Conversion +52,647 54,083
2020-07-21 GOODMAN COREY S Director Conversion · Series A Convertible Stock −3,100,020 0
2020-07-21 GOODMAN COREY S Director Conversion · Series A Convertible Stock −2,398,588 0
2020-07-21 GOODMAN COREY S Director Conversion · Series B Convertible Stock −490,411 0
2020-07-21 GOODMAN COREY S Director Conversion · Series C Convertible Stock −1,052,950 0
2020-07-21 GOODMAN COREY S Director Conversion · Series A Convertible Stock −78,175 0
2020-07-21 GOODMAN COREY S Director Conversion · Series B Convertible Stock −15,794 0
2020-07-21 GOODMAN COREY S Director Conversion · Series C Convertible Stock −52,647 0
2020-07-21 Pietzke Steffen VP Fin & Chief Acct Officer Purchase +3,000 $19.00 $57K 3,000
2020-07-21 GARCIA PETER S Chief Financial Officer Purchase +3,000 $19.00 $57K 3,000
2020-07-21 Caffo Nathan Chief Business Officer Conversion +10,529 11,254
2020-07-21 Caffo Nathan Chief Business Officer Conversion · Series B Convertible Preferred Stock −10,529 0
2020-07-21 Pons Jaume President and CEO Conversion +27,292 541,346
2020-07-21 Pons Jaume President and CEO Conversion · Series A Convertible Preferred Stock −20,225 0
2020-07-21 Pons Jaume President and CEO Conversion · Series A Convertible Preferred Stock −1,803 0

Page 21 of 22 · 432 trades